StreetInsider.com News Articles

Waters launches BD FACSDiscover A7 Cell Analyzer globally

Mon, 14 Sep 2026 08:00:42 -0400

Waters Corporation (NYSE: WAT) announced the global commercial launch of the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometry instrument designed for use in academic, pharmaceutical, and contract research organization laboratories.

The instrument incorporates BD SpectralFX Technology, which supports up to five lasers and 78 fluorescence detectors, enabling researchers to analyze more than 50 characteristics of a single cell. The A7 expands Waters' existing FACSDiscover platform, which includes the BD FACSDiscover A8 Cell Analyzer.

The A7 includes FACSTruQ Technology, an automated calibration and quality control system that Waters says achieves a coefficient of variation of less than 10% across a palette

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Mon, 14 Sep 2026 08:00:00 -0400

Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Mon, 14 Sep 2026 08:00:00 -0400

Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.

Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference

Fri, 11 Sep 2026 09:00:00 -0400

MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference on Wednesday, September 23, 2026, at 12:00 PM BST (GMT+1) / 7:00 AM Eastern Time.

A live webcast of the event will be available

Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference

Fri, 11 Sep 2026 09:00:00 -0400

A live webcast of the event will be available

UBS Assumes Waters Corp. (WAT) at Buy

Wed, 09 Sep 2026 06:07:42 -0400

UBS analyst Douglas Schenkel assumes coverage on Waters Corp. (NYSE: WAT) with a Buy rating and a price target of $490.00.

For an analyst ratings summary and ratings history on Waters Corp. click here. For more ratings news on Waters Corp. click here.

Shares of Waters Corp. closed at $402.91 yesterday.

Waters Corp. (WAT) PT Raised to $456 at Baird

Thu, 03 Sep 2026 07:06:39 -0400

Baird analyst Catherine Schulte raised the price target on Waters Corp. (NYSE: WAT) to $456.00 (from $434.00) while maintaining a Outperform rating.

Waters Corp. (WAT) PT Raised to $455 at HSBC

Tue, 01 Sep 2026 02:17:06 -0400

HSBC analyst Shubhangi Gupta raised the price target on Waters Corp. (NYSE: WAT) to $455.00 (from $450.00) while maintaining a Buy rating.

Form 3 WATERS CORP /DE/ For: Aug 21 Filed by: Wu Tong (NMN)

Mon, 31 Aug 2026 18:10:00 -0400

si-local-file:///var/storage/secattach/20260831/27007081.html

Morgan Stanley sees Waters best positioned after China lab pricing rules

Mon, 31 Aug 2026 12:02:04 -0400

Investing.com -- Morgan Stanley analysts said Waters Corporation appears best positioned among life science diagnostic companies following China's finalized clinical laboratory service pricing framework, which was published a couple of weeks ago by the National Healthcare Security Administration.

The framework covers 662 main items, 114 add-ons, and seven extensions. It preserves the methodology-neutral structure proposed in March and retains differentiated treatment for advanced workflows including mass spectrometry. The guidelines introduce tiered discounts for multiplex panels and provide more detailed treatment of certain microbiology services. Provincial authorities will determine actual pricing in Chinese yuan and implementation timing.

Morgan Stanley said Waters benefits from

Morgan Stanley sees Waters best positioned after China lab pricing rules

Mon, 31 Aug 2026 12:02:04 -0400

Morgan Stanley said Waters benefits from

Piper Sandler Upgrades Waters Corp. (WAT) to Overweight

Thu, 27 Aug 2026 05:06:02 -0400

Piper Sandler analyst David Westenberg upgraded Waters Corp. (NYSE: WAT) from Neutral to Overweight with a price target of $480.00.

For an analyst ratings summary and ratings history on Waters Corp. click here. For more ratings news on Waters Corp. click here.

Shares of Waters Corp. closed at $414.17 yesterday.

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Wed, 26 Aug 2026 09:00:00 -0400

MILFORD, Mass., Aug. 26, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Wells Fargo 21^st Annual Healthcare Conference on Wednesday, September 9th, 2026, at 10:15 AM Eastern Time.

A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.

About Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Wed, 26 Aug 2026 09:00:00 -0400

About Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Wed, 26 Aug 2026 09:00:00 -0400

About Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Wed, 26 Aug 2026 09:00:00 -0400

About Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in

Form 8-K WATERS CORP /DE/ For: Aug 17

Fri, 21 Aug 2026 09:21:00 -0400

si-local-file:///var/storage/secattach/20260821/26959114.html

Form 8-K WATERS CORP /DE/ For: Aug 17

Fri, 21 Aug 2026 09:21:00 -0400

si-local-file:///var/storage/secattach/20260821/26959114.html

Form 10-Q WATERS CORP /DE/ For: Jul 04

Tue, 11 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260811/26906000.html

Form 10-Q WATERS CORP /DE/ For: Jul 04

Tue, 11 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260811/26906000.html

Form 4 WATERS CORP /DE/ For: Aug 06 Filed by: KUEBLER CHRISTOPHER A

Fri, 07 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260807/26892231.html

Form 4 WATERS CORP /DE/ For: Aug 06 Filed by: KUEBLER CHRISTOPHER A

Fri, 07 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260807/26892231.html

Form 144 WATERS CORP /DE/ Filed by: KUEBLER CHRISTOPHER A

Thu, 06 Aug 2026 10:40:00 -0400

si-local-file:///var/storage/secattach/20260806/26881370.html

Form 144 WATERS CORP /DE/ Filed by: KUEBLER CHRISTOPHER A

Thu, 06 Aug 2026 10:40:00 -0400

si-local-file:///var/storage/secattach/20260806/26881370.html

Waters Corp. (WAT) PT Raised to $430 at Morgan Stanley

Thu, 06 Aug 2026 08:53:42 -0400

Morgan Stanley analyst Kallum Titchmarsh raised the price target on Waters Corp. (NYSE: WAT) to $430.00 (from $390.00) while maintaining a Equalweight rating.